Examkin

Question

Difficulty: HardInfectious Disease Mechanisms

A 78-year-old woman is evaluated in the hospital for severe, watery diarrhea, abdominal cramping, and fever. She was admitted 5 days ago for a community-acquired pneumonia treated with ceftriaxone and azithromycin. Temperature is 38.6°C (101.5°F), blood pressure is 90/60 mm Hg, and pulse is 112/min. Physical examination reveals a distended, diffusely tender abdomen with guarding. Laboratory studies show a leukocyte count of 28,000/mm³ and a serum creatinine of 1.9 mg/dL. Flexible sigmoidoscopy reveals raised, yellowish-white plaques adherent to the colonic mucosa. Stool testing is positive for a highly virulent organism's exotoxins. The patient's condition is primarily driven by bipartite large clostridial toxins. Arrange the following cellular events in the correct chronological pathophysiological sequence mediating this toxin's intracellular effect.

  1. 1Binding of the toxin's C-terminal domain to colonic epithelial cell receptors
  2. 2Internalization into an endosome followed by acidification-driven membrane insertion
  3. 3Host inositol hexakisphosphate (IP6)-induced autoproteolytic cleavage
  4. 4Covalent transfer of a glucose moiety to host Rho family GTPases
  5. 5Disruption of the actin cytoskeleton and subsequent cellular apoptosis

Answer

The correct chronological sequence is: Binding of the toxin -> Internalization and endosomal insertion -> IP6-induced autoproteolytic cleavage -> Glycosylation of Rho family GTPases -> Disruption of the actin cytoskeleton.
The pathophysiology of Clostridioides difficile Toxins A and B follows a highly orchestrated multi-step intracellular delivery cascade. The C-terminal domain of the toxin first binds to specific host cell receptors. The complex is then internalized into early endosomes via receptor-mediated endocytosis. As the endosome acidifies, the toxin undergoes a conformational change that allows its translocation domain to insert into the membrane, forming a pore. The N-terminal enzymatic domain is translocated to the cytosolic side, where the binding of host cytosolic inositol hexakisphosphate (IP6) triggers the toxin's built-in autoprotease activity. This cleavage releases the active glucosyltransferase domain into the cytosol. Finally, this active domain covalently attaches a glucose molecule to Rho family GTPases, irreversibly inactivating them. The loss of Rho GTPase function causes collapse of the actin cytoskeleton, leading to cell rounding, apoptosis, and the loss of the colonic epithelial barrier (pseudomembranous colitis).

Step-by-Step Solution

1
Identify the clinical syndrome and causative organism.
The patient has severe pseudomembranous colitis caused by Clostridioides difficile.
Recent antibiotic use, marked leukocytosis, and characteristic yellow-white colonic plaques are pathognomonic.
2
Identify the primary virulence factors.
C. difficile produces Toxin A (TcdA, an enterotoxin) and Toxin B (TcdB, a cytotoxin).
Both are large clostridial toxins that share a similar tripartite structure and intracellular mechanism of action.
3
Trace the initial cellular entry of the toxin.
The toxin binds to surface receptors and is internalized into early endosomes.
Extracellular large toxins must gain access to the intracellular cytosolic space to exert their enzymatic effects.
4
Determine how the active domain escapes the endosome into the cytosol.
Endosomal acidification drives membrane insertion, followed by host IP6-dependent autoproteolysis.
The low pH alters the toxin conformation to form a pore, and host cytosolic IP6 acts as a specific trigger to cleave and release the glucosyltransferase domain exactly where it is needed.
5
Identify the ultimate enzymatic target and physiological consequence.
The toxin glycosylates Rho GTPases, causing actin depolymerization.
Rho family proteins dynamically control the actin cytoskeleton; their targeted inactivation leads to cell rounding, barrier breakdown, and cell death, creating the mucosal pseudomembranes.

Key Concept

Clostridioides difficile Toxins A and B (large clostridial toxins) mediate their cellular destruction through a tightly regulated sequence: receptor binding, endocytosis, IP6-induced autoproteolysis, and the glycosylation of Rho GTPases, which ultimately disrupts the actin cytoskeleton.
Estimated Time:1m 30s
Rate this question

Topics

Infectious Disease Mechanisms

More questions from this topic